JPWO2023077070A5 - - Google Patents
Info
- Publication number
- JPWO2023077070A5 JPWO2023077070A5 JP2024525593A JP2024525593A JPWO2023077070A5 JP WO2023077070 A5 JPWO2023077070 A5 JP WO2023077070A5 JP 2024525593 A JP2024525593 A JP 2024525593A JP 2024525593 A JP2024525593 A JP 2024525593A JP WO2023077070 A5 JPWO2023077070 A5 JP WO2023077070A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- cycloalkyl
- heteroatoms selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273242P | 2021-10-29 | 2021-10-29 | |
| US63/273,242 | 2021-10-29 | ||
| PCT/US2022/078879 WO2023077070A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540163A JP2024540163A (ja) | 2024-10-31 |
| JP2024540163A5 JP2024540163A5 (https=) | 2025-10-30 |
| JPWO2023077070A5 true JPWO2023077070A5 (https=) | 2025-10-30 |
Family
ID=84363771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525593A Pending JP2024540163A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250011288A1 (https=) |
| EP (1) | EP4423068B1 (https=) |
| JP (1) | JP2024540163A (https=) |
| KR (1) | KR20240091018A (https=) |
| CN (1) | CN118510758A (https=) |
| ES (1) | ES3062200T3 (https=) |
| WO (1) | WO2023077070A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121605099A (zh) * | 2023-08-10 | 2026-03-03 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| TW202530177A (zh) * | 2023-10-13 | 2025-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 醯胺取代的環烷基類化合物、其製備方法及其在醫藥上的應用 |
| JP7788532B2 (ja) * | 2023-12-15 | 2025-12-18 | イーライ リリー アンド カンパニー | Ｒｘｆｐ１受容体アゴニスト |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
| WO2026064271A1 (en) * | 2024-09-23 | 2026-03-26 | Fmc Corporation | Substituted bicyclic amide derivatives as herbicides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2803920A1 (en) | 2010-06-24 | 2011-12-29 | Richard Beard | Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| WO2013165606A1 (en) * | 2012-05-04 | 2013-11-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| AR124193A1 (es) * | 2020-12-08 | 2023-02-22 | Astrazeneca Ab | Compuestos moduladores de rxfp1 |
-
2022
- 2022-10-28 WO PCT/US2022/078879 patent/WO2023077070A1/en not_active Ceased
- 2022-10-28 CN CN202280083558.3A patent/CN118510758A/zh active Pending
- 2022-10-28 US US18/701,270 patent/US20250011288A1/en active Pending
- 2022-10-28 KR KR1020247017525A patent/KR20240091018A/ko active Pending
- 2022-10-28 EP EP22813850.9A patent/EP4423068B1/en active Active
- 2022-10-28 ES ES22813850T patent/ES3062200T3/es active Active
- 2022-10-28 JP JP2024525593A patent/JP2024540163A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| RU2005111975A (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| JP2022137237A5 (https=) | ||
| RU2007124681A (ru) | Производные тетрагидропирана в качестве противодиабетических средств | |
| JPS595165A (ja) | １−アリ−ルオキシ−２，３，４，５−テトラヒドロ−３−ベンズアゼピンおよびその製法 | |
| RU2009135389A (ru) | Четвертичные аммониевые дифенилметилсоединения, применимые в качестве антагонистов мускариновых рецепторов | |
| JPWO2023077070A5 (https=) | ||
| DE69434720T2 (de) | Verwendung von 2,6-Dialkyl-4-Silyl-Phenol Derivaten zur Behandlung von Xanthom | |
| JP2021513543A5 (https=) | ||
| JPWO2020106642A5 (https=) | ||
| JP2020516616A5 (https=) | ||
| CH630068A5 (en) | Process for the preparation of 4-hydroxyphenylalkanolamine derivatives | |
| JPWO2023088233A5 (https=) | ||
| JPWO2023077040A5 (https=) | ||
| AU618013B2 (en) | Stable oxapenem- 3-carboxylic acids | |
| SK159995A3 (en) | Novel (1-phenyl-1-heterocyclyl)alkane derivatives and their use as neuroprotective agents | |
| AU759030B2 (en) | 2-aroyl-4-acyl paclitaxel (taxol) analogs | |
| RU2012152800A (ru) | Гидроксиалкилбензилпиразолы и их применение для лечения гиперпролиферативных и ангиогенных заболеваний | |
| RU2008112181A (ru) | Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3 | |
| JPWO2023066283A5 (https=) | ||
| FR2726267A1 (fr) | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer | |
| JPS6112909B2 (https=) | ||
| JPWO2023114822A5 (https=) | ||
| JPWO2023076626A5 (https=) | ||
| CN114349745B (zh) | 一种用于治疗心肌缺血的药物及其制备方法 |